Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies
NCT05419180
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Pharmacoresistant Focal Epilepsies
Interventions
DRUG:
Stiripentol
Sponsor
Biocodex